Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice.
暂无分享,去创建一个
P. Denev | K. Tasheva | R. Kalfin | L. Tancheva | M. Lazarova | A. Georgieva | D. Uzunova | M. Stefanova | E. Tsvetanova | Elina R Tsvetanova | Elina R. Tsvetanova
[1] R. Bateman,et al. Lecanemab in Early Alzheimer's Disease. , 2022, The New England journal of medicine.
[2] K. E. Malterud,et al. Immunomodulating polyphenols from Sideritis scardica , 2022, Journal of Functional Foods.
[3] E. Mavrogonatou,et al. Phytochemical Study and In Vitro Screening Focusing on the Anti-Aging Features of Various Plants of the Greek Flora , 2021, Antioxidants.
[4] Ming-Hua Yang,et al. Estimation of total flavonoid content in propolis by two complementary colometric methods , 2020, Journal of Food and Drug Analysis.
[5] P. Chatzopoulou,et al. NMR-Based Chemical Profiling, Isolation and Evaluation of the Cytotoxic Potential of the Diterpenoid Siderol from Cultivated Sideritis euboea Heldr. , 2020, Molecules.
[6] M. Sulaiman,et al. Effect of zerumbone on scopolamine-induced memory impairment and anxiety-like behaviours in rats , 2019, Alzheimer's & dementia.
[7] H. Demirelma. DETERMINATION OF THE CYTOTOXIC EFFECT ON HUMAN COLON CANCER AND PHENOLIC SUBSTANCE CONTENT OF THE ENDEMIC SPECIES SIDERITIS OZTURKII AYTAÇ & AKSOY , 2019, Applied Ecology and Environmental Research.
[8] M. Wink,et al. Sideritis scardica extracts inhibit aggregation and toxicity of amyloid-β in Caenorhabditis elegans used as a model for Alzheimer’s disease , 2018, PeerJ.
[9] G. Lubec,et al. Spatial Working Memory in Male Rats: Pre-Experience and Task Dependent Roles of Dopamine D1- and D2-Like Receptors , 2017, Front. Behav. Neurosci..
[10] G. Lubec,et al. Repeated application of Modafinil and Levodopa reveals a drug-independent precise timing of spatial working memory modulation , 2016, Behavioural Brain Research.
[11] W. Dimpfel,et al. Ex Vivo Characterization of the Action of Sideritis Extract Using Electrical Activity in the Rat Hippocampus Slice Preparation , 2016 .
[12] K. Blennow,et al. Alzheimer's disease , 2016, The Lancet.
[13] M. Krohn,et al. Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer’s β-Amyloidosis Mouse Models and Aged C57Bl/6 Mice , 2016, Journal of Alzheimer's disease : JAD.
[14] A. Hahn,et al. Effect of an herbal extract of Sideritis scardica and B-vitamins on cognitive performance under stress: a pilot study , 2016 .
[15] W. Dimpfel,et al. Psychophysiological Effects of Sideritis and Bacopa Extract and Three Combinations Thereof-A Quantitative EEG Study in Subjects Suffering from Mild Cognitive Impairment (MCI) , 2016 .
[16] T. H. Ferreira-Vieira,et al. Alzheimer's Disease: Targeting the Cholinergic System , 2016, Current neuropharmacology.
[17] C. Calandra,et al. The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia , 2015, Oxidative medicine and cellular longevity.
[18] J. Stanoeva,et al. Chemotaxonomic contribution to the Sideritis species dilemma on the Balkans , 2015 .
[19] Bombi Lee,et al. Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats , 2014, BMC Complementary and Alternative Medicine.
[20] Nirmal Singh,et al. Animal models of dementia and cognitive dysfunction. , 2014, Life sciences.
[21] A. Trendafilova,et al. Sideritis scardica Griseb., an endemic species of Balkan peninsula: traditional uses, cultivation, chemical composition, biological activity. , 2014, Journal of ethnopharmacology.
[22] Torbjörn Persson,et al. Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail? , 2014, Oxidative medicine and cellular longevity.
[23] P. Kroon,et al. Bioactive-rich Sideritis scardica tea (mountain tea) is as potent as Camellia sinensis tea at inducing cellular antioxidant defences and preventing oxidative stress. , 2013, Journal of the science of food and agriculture.
[24] M. Stefova,et al. Assay of urinary excretion of polyphenols after ingestion of a cup of mountain tea (Sideritis scardica) measured by HPLC-DAD-ESI-MS/MS. , 2013, Journal of agricultural and food chemistry.
[25] V. Trajković,et al. The Mechanisms of In Vitro Cytotoxicity of Mountain Tea, Sideritis scardica, against the C6 Glioma Cell Line , 2013, Planta Medica.
[26] W. Dimpfel. Pharmacological classification of herbal extracts by means of comparison to spectral EEG signatures induced by synthetic drugs in the freely moving rat. , 2013, Journal of ethnopharmacology.
[27] Henry Brodaty,et al. Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future , 2013, Alzheimer's & Dementia.
[28] G. Stefkov,et al. Chemical Characterization, Mineral Content and Radical Scavenging Activity of Sideritis scardica and S. raeseri from R. Macedonia and R. Albania , 2013 .
[29] A. Cavalli,et al. Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease , 2013, PloS one.
[30] P. Koh. Ferulic acid modulates nitric oxide synthase expression in focal cerebral ischemia , 2012, Laboratory animal research.
[31] R. Knörle. Extracts of Sideritis scardica as triple monoamine reuptake inhibitors , 2012, Journal of Neural Transmission.
[32] K. Jellinger,et al. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.
[33] A. Mahadevan,et al. Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease , 2012, Neurochemical Research.
[34] P. Goverdhan,et al. Neuroprotective Effects of Meloxicam and Selegiline in Scopolamine-Induced Cognitive Impairment and Oxidative Stress , 2012, International journal of Alzheimer's disease.
[35] V. Trajković,et al. Anti-inflammatory, gastroprotective, and cytotoxic effects of Sideritis scardica extracts. , 2012, Planta medica.
[36] A. Tzakos,et al. Phytochemical composition of “mountain tea” from Sideritis clandestina subsp. clandestina and evaluation of its behavioral and oxidant/antioxidant effects on adult mice , 2013, European Journal of Nutrition.
[37] Julie S Snowden,et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. , 2011, Brain : a journal of neurology.
[38] B. Hyman,et al. Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.
[39] C. Constantinou,et al. Differential antioxidant effects of consuming tea from Sideritis clandestina subsp. peloponnesiaca on cerebral regions of adult mice. , 2011, Journal of medicinal food.
[40] W. Gattaz,et al. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models , 2011, Clinics.
[41] F. Tomás-Barberán,et al. Potential bioactive phenolics of Macedonian Sideritis species used for medicinal “Mountain Tea” , 2011 .
[42] M. Stefova,et al. Phenolic Compounds of Mountain Tea from the Balkans: LC/DAD/ESI/MSn Profile and Content , 2011, Natural product communications.
[43] P. Denev,et al. Solid-phase extraction of berries’ anthocyanins and evaluation of their antioxidative properties , 2010 .
[44] M. Valko,et al. Metals, oxidative stress and neurodegenerative disorders , 2010, Molecular and Cellular Biochemistry.
[45] P. Denev,et al. Evaluation of antioxidant activity of medicinal plants containing polyphenol compounds. Comparison of two extraction systems. , 2010, Acta biochimica Polonica.
[46] Wen-Jing Chu,et al. Functional activation of monoamine transporters by luteolin and apigenin isolated from the fruit of Perilla frutescens (L.) Britt , 2010, Neurochemistry International.
[47] D. Perl. Neuropathology of Alzheimer's disease. , 2010, The Mount Sinai journal of medicine, New York.
[48] J. Laranjinha,et al. Dietary polyphenols generate nitric oxide from nitrite in the stomach and induce smooth muscle relaxation. , 2009, Toxicology.
[49] Yasuomi Ouchi,et al. Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease , 2009, Journal of Nuclear Medicine.
[50] H. Jacobsen,et al. Alzheimer's disease: from pathology to therapeutic approaches. , 2009, Angewandte Chemie.
[51] M. Boğa,et al. Antioxidant and anticholinesterase activity evaluation of ent-kaurane diterpenoids from Sideritis arguta. , 2009, Journal of natural products.
[52] M. Smith,et al. Causes of oxidative stress in Alzheimer disease , 2007, Cellular and Molecular Life Sciences.
[53] Irfan Rahman,et al. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method , 2006, Nature Protocols.
[54] A. Fujii,et al. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats , 2006, Journal of hypertension.
[55] Gabriele Siciliano,et al. Mitochondrial dysfunction, oxidative stress and neurodegeneration. , 2006, Journal of Alzheimer's disease : JAD.
[56] C. Hulette,et al. Neuropathology of Alzheimer's disease. , 2005, Neuroimaging clinics of North America.
[57] Atta-ur-rahman,et al. Trends in ethnopharmacology , 2005 .
[58] K. Başer,et al. Antioxidant Properties and Phenolic Composition of Sideritis Species , 2004, Chemistry of Natural Compounds.
[59] G. Reynolds,et al. Monoamine neurotransmitters and their metabolites in brain regions in alzheimer's disease: A postmortem study , 1992, Cellular and Molecular Neurobiology.
[60] E. Giacobini,et al. Cholinergic function and Alzheimer's disease , 2003, International journal of geriatric psychiatry.
[61] J. Karlawish,et al. Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies , 2003, Annals of Internal Medicine.
[62] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[63] Dejian Huang,et al. Analysis of antioxidant activities of common vegetables employing oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays: a comparative study. , 2002, Journal of agricultural and food chemistry.
[64] Robert Lalonde,et al. The neurobiological basis of spontaneous alternation , 2002, Neuroscience & Biobehavioral Reviews.
[65] S. File,et al. Factors controlling measures of anxiety and responses to novelty in the mouse , 2001, Behavioural Brain Research.
[66] R. Prior,et al. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. , 2001, Journal of agricultural and food chemistry.
[67] L. T. McGrath,et al. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. , 2001, QJM : monthly journal of the Association of Physicians.
[68] C. Lyketsos,et al. Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study. , 2000, The American journal of psychiatry.
[69] G. Wilcock,et al. The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.
[70] W. D. Ehmann,et al. Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease , 1997, Neurobiology of Aging.
[71] J. Medina,et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. , 1995, Planta medica.
[72] Barry Halliwell,et al. Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.
[73] Á. Pazos,et al. High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia , 1991, Brain Research.
[74] E. Giacobini. Chapter 34 The cholinergic system in Alzheimer disease , 1990 .
[75] G. Reynolds,et al. Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata , 1989, Neuroscience Letters.
[76] D. Price,et al. The neuropathology of aminergic nuclei in Alzheimer's disease , 1988, Progress in clinical and biological research.
[77] D. Neary,et al. Presynaptic Serotonergic Dysfunction in Patients with Alzheimer's Disease , 1987, Journal of neurochemistry.
[78] P. Mcgeer,et al. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain , 1984, Neurology.
[79] J. Coyle,et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.
[80] D. Jacobowitz,et al. Method for the rapid determination of norepinephrine, dopamine, and serotonin in the same brain region , 1978, Pharmacology Biochemistry and Behavior.
[81] M. Jarvik,et al. An Improved One-Trial Passive Avoidance Learning Situation , 1967, Psychological reports.
[82] K. Courtney,et al. A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.
[83] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.